High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy

Lade...
Vorschaubild
Dateien
Amelio_2-x18yovgcjn4p8.pdf
Amelio_2-x18yovgcjn4p8.pdfGröße: 2.38 MBDownloads: 23
Datum
2014
Autor:innen
Rossi, Marco
Rotblat, Barak
Ansell, Keith
Caraglia, Michele
Misso, Gabriella
Bernassola, Fancesca
Knight, Richard A.
Ciechanover, Aaron
Melino, Gerry
et al.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Cell death & disease. Nature Publishing Group. 2014, 5, e1203. eISSN 2041-4889. Available under: doi: 10.1038/cddis.2014.113
Zusammenfassung

Inhibition of distinct ubiquitin E3 ligases might represent a powerful therapeutic tool. ITCH is a HECT domain-containing E3 ligase that promotes the ubiquitylation and degradation of several proteins, including p73, p63, c-Jun, JunB, Notch and c-FLIP, thus affecting cell fate. Accordingly, ITCH depletion potentiates the effect of chemotherapeutic drugs, revealing ITCH as a potential pharmacological target in cancer therapy. Using high throughput screening of ITCH auto-ubiquitylation, we identified several putative ITCH inhibitors, one of which is clomipramine--a clinically useful antidepressant drug. Previously, we have shown that clomipramine inhibits autophagy by blocking autophagolysosomal fluxes and thus could potentiate chemotherapy in vitro. Here, we found that clomipramine specifically blocks ITCH auto-ubiquitylation, as well as p73 ubiquitylation. By screening structural homologs of clomipramine, we identified several ITCH inhibitors and putative molecular moieties that are essential for ITCH inhibition. Treating a panel of breast, prostate and bladder cancer cell lines with clomipramine, or its homologs, we found that they reduce cancer cell growth, and synergize with gemcitabine or mitomycin in killing cancer cells by blocking autophagy. We also discuss a potential mechanism of inhibition. Together, our study (i) demonstrates the feasibility of using high throughput screening to identify E3 ligase inhibitors and (ii) provides insight into how clomipramine and its structural homologs might interfere with ITCH and other HECT E3 ligase catalytic activity in (iii) potentiating chemotherapy by regulating autophagic fluxes. These results may have direct clinical applications.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
HECT, ubiquitin, E3 ligase, inhibitors, autophagy, antidepressant
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690ROSSI, Marco, Barak ROTBLAT, Keith ANSELL, Ivano AMELIO, Michele CARAGLIA, Gabriella MISSO, Fancesca BERNASSOLA, Richard A. KNIGHT, Aaron CIECHANOVER, Gerry MELINO, 2014. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. In: Cell death & disease. Nature Publishing Group. 2014, 5, e1203. eISSN 2041-4889. Available under: doi: 10.1038/cddis.2014.113
BibTex
@article{Rossi2014-05-01throu-57118,
  year={2014},
  doi={10.1038/cddis.2014.113},
  title={High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy},
  volume={5},
  journal={Cell death & disease},
  author={Rossi, Marco and Rotblat, Barak and Ansell, Keith and Amelio, Ivano and Caraglia, Michele and Misso, Gabriella and Bernassola, Fancesca and Knight, Richard A. and Ciechanover, Aaron and Melino, Gerry},
  note={Article Number: e1203}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/57118">
    <dc:contributor>Amelio, Ivano</dc:contributor>
    <dc:creator>Ansell, Keith</dc:creator>
    <dc:contributor>Caraglia, Michele</dc:contributor>
    <dc:contributor>Melino, Gerry</dc:contributor>
    <dc:contributor>Ciechanover, Aaron</dc:contributor>
    <dc:creator>Caraglia, Michele</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-31T12:54:59Z</dc:date>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57118/3/Amelio_2-x18yovgcjn4p8.pdf"/>
    <dc:contributor>Bernassola, Fancesca</dc:contributor>
    <dcterms:abstract xml:lang="eng">Inhibition of distinct ubiquitin E3 ligases might represent a powerful therapeutic tool. ITCH is a HECT domain-containing E3 ligase that promotes the ubiquitylation and degradation of several proteins, including p73, p63, c-Jun, JunB, Notch and c-FLIP, thus affecting cell fate. Accordingly, ITCH depletion potentiates the effect of chemotherapeutic drugs, revealing ITCH as a potential pharmacological target in cancer therapy. Using high throughput screening of ITCH auto-ubiquitylation, we identified several putative ITCH inhibitors, one of which is clomipramine--a clinically useful antidepressant drug. Previously, we have shown that clomipramine inhibits autophagy by blocking autophagolysosomal fluxes and thus could potentiate chemotherapy in vitro. Here, we found that clomipramine specifically blocks ITCH auto-ubiquitylation, as well as p73 ubiquitylation. By screening structural homologs of clomipramine, we identified several ITCH inhibitors and putative molecular moieties that are essential for ITCH inhibition. Treating a panel of breast, prostate and bladder cancer cell lines with clomipramine, or its homologs, we found that they reduce cancer cell growth, and synergize with gemcitabine or mitomycin in killing cancer cells by blocking autophagy. We also discuss a potential mechanism of inhibition. Together, our study (i) demonstrates the feasibility of using high throughput screening to identify E3 ligase inhibitors and (ii) provides insight into how clomipramine and its structural homologs might interfere with ITCH and other HECT E3 ligase catalytic activity in (iii) potentiating chemotherapy by regulating autophagic fluxes. These results may have direct clinical applications.</dcterms:abstract>
    <dc:creator>Misso, Gabriella</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-31T12:54:59Z</dcterms:available>
    <dc:creator>Melino, Gerry</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57118/3/Amelio_2-x18yovgcjn4p8.pdf"/>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dc:language>eng</dc:language>
    <dc:creator>Bernassola, Fancesca</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:rights>terms-of-use</dc:rights>
    <dc:contributor>Ansell, Keith</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57118"/>
    <dc:creator>Knight, Richard A.</dc:creator>
    <dc:contributor>Rossi, Marco</dc:contributor>
    <dc:creator>Rossi, Marco</dc:creator>
    <dc:contributor>Misso, Gabriella</dc:contributor>
    <dc:creator>Rotblat, Barak</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Knight, Richard A.</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:issued>2014-05-01</dcterms:issued>
    <dcterms:title>High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy</dcterms:title>
    <dc:contributor>Rotblat, Barak</dc:contributor>
    <dc:creator>Ciechanover, Aaron</dc:creator>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja
Diese Publikation teilen